British American Tobacco PLC ADR (0A76)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 59.25 |
|---|---|
| 52-week range | 46.21 – 65.43 |
| Return, 1 month / 3 months | +8.1% / −2.2% |
| Return, 1 year / 3 years | +24.5% / +138.1% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 25.5% |
| Worst drawdown (1 year) | -20.3% |
| Average daily value traded | 2.16M USD |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
British American Tobacco is a tobacco company based in London that makes and sells cigarettes and other nicotine products to adult consumers in markets around the world. Its cigarette brands include Dunhill, Kent, Lucky Strike and Pall Mall, and it also offers vaping devices and e-liquids under Vuse and oral nicotine pouches under Velo. The company supplies wholesalers, retailers and distributors across many countries, and its products reach customers through shops and other retail channels.
On this site British American Tobacco PLC ADR appears as a stock on the London Exchange (UK), code 0A76, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
British American Tobacco PLC ADR (0A76) trades on the London Exchange in UK. It last closed at USD 59.25 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 964 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.5% and over the last three months it fell 2.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -8.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.2% | ||
| 6-month return | 8.6% | ||
| 12-month return, skipping the last month | 15.2% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.3% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.16M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | +8.1% |
| 3 months | −2.2% |
| 6 months | +8.6% |
| 1 year | +24.5% |
| 3 years | +138.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 55.35 / 57.20 |
|---|---|
| Golden / death cross (60 days) | Death, 20 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Oct 2026 | GBP 0.8349 |
| 10 Jul 2026 | GBP 0.8200 |
| 27 Mar 2026 | GBP 0.8240 |
| 30 Dec 2025 | GBP 0.8234 |
| 3 Oct 2025 | GBP 0.7391 |
| 27 Jun 2025 | GBP 0.7874 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.